In our in vitro studies, overexpression of miR-101-3p in β-cells enhanced glucose-stimulated insulin secretion, suggesting that its upregulation in T2D may be involved in a compensatory mechanism to enhance insulin secretion. This evidence concerns the gene INS and type 2 diabetes mellitus.